SCHEMBL23735915

SCHEMBL23735915

CC(C)N1CCNCC12CN(C)C2

nearest known ligand 0.41

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ SOS1 Q07889 1/20 0.41
▸ SOS2 Q07890 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17789639 0.82 SOS1 (0.45) SOS1SOS2
SCHEMBL27443832 0.78 SOS1 (0.52) SOS1SOS2
SCHEMBL20334424 0.78 SOS1 (0.31) SOS1SOS2
SCHEMBL25859586 0.77 SOS1 (0.37) SOS1SOS2
SCHEMBL25724486 0.73 — —
SCHEMBL20334425 0.73 — —
SCHEMBL24720256 0.72 SOS1 (0.39) SOS1SOS2
SCHEMBL25785222 0.72 SOS1 (0.37) SOS1SOS2
SCHEMBL25785225 0.72 SOS1 (0.37) SOS1SOS2
SCHEMBL25634055 0.72 SOS1 (0.37) SOS1SOS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3558955-B1 BENZISOTHIAZOLE, ISOTHIAZOLO[3,4-B]PYRIDINE, QUINAZOLINE, PHTHALAZINE, PYRIDO[2,3-D]PYRIDAZINE AND PYRIDO[2,3-D]PYRIMIDINE DERIVATIVES AS KRAS G12C INHIBITORS FOR TREATING LUNG, PANCREATIC OR COLORECTAL CANCER AMGEN INC (US) 2021-08-11 — — EP disclosed
Send feedback